<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345346</id>
  <title nil="true"/>
  <common-name>2,2,4,4-tetramethyl-1-(4-propan-2-ylphenyl)-3-(4-pyridin-2-ylpiperazin-1-yl)cyclobutan-1-ol</common-name>
  <description>2,2,4,4-tetramethyl-1-(4-propan-2-ylphenyl)-3-(4-pyridin-2-ylpiperazin-1-yl)cyclobutan-1-ol is a chemical compound with the formula C26H37N3O. It has an average molecular weight of 407.60 g/mol.</description>
  <cas>53087-69-7</cas>
  <pubchem-id>3040919</pubchem-id>
  <chemical-formula>C26H37N3O</chemical-formula>
  <weight>407.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:01:58Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:01:58Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)C1=CC=C(C=C1)C2(C(C(C2(C)C)N3CCN(CC3)C4=CC=CC=N4)(C)C)O</moldb-smiles>
  <moldb-formula>C26H37N3O</moldb-formula>
  <moldb-inchi>InChI=1S/C26H37N3O/c1-19(2)20-10-12-21(13-11-20)26(30)24(3,4)23(25(26,5)6)29-17-15-28(16-18-29)22-9-7-8-14-27-22/h7-14,19,23,30H,15-18H2,1-6H3</moldb-inchi>
  <moldb-inchikey>OUCVMOGIAOHMQH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">407.2936628</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341239</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2,2,4,4-tetramethyl-1-(4-propan-2-ylphenyl)-3-(4-pyridin-2-ylpiperazin-1-yl)cyclobutan-1-ol</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0295706</sync-id>
  <structure-inchikey>OUCVMOGIAOHMQH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000000000000000000000000000000000001000000000000000000000000000000100000000000000000000000200000010000000000800000000800000000012000100840000000020000000000000000000000000000000000000000080000000001000000000000000001000000000002010000000000000000000010000000004800000080000000000000003000010000010000000000000000002000000000000000000000042008000000000000400008000000800000080000a000000000000000000000000000000000000000000000000000800200000000000008000000000006002040000000000000000000000200000000000010000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAeAAAAIQAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:25Z</structure-indexed-at>
</compound>
